Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Laureth 4 💬[1] Polidocanol (Polyethylene glycol 450 lauryl ether)[1] Polidocanol--[3] 34, 278, 279 💬
2 Macrogol 4000 💬[1] Polyethylene glycol (Polyethylene glycol)[3] Macrogol; Macrogol 3350; Polyethylene glycol--[4] 50, 97, 195, 299 💬
3 Macrogol 6000 💬[1] Polyethylene glycol (Polyethylene glycol)[3] Macrogol; Macrogol 3350; Polyethylene glycol--[4] 50, 97, 195, 299 💬
4 Peginterferon beta-1a 💬[1] Peginterferon beta-1a (Polyethylene glycol-interferon beta-1a)[1] Peginterferon BETA-1A[2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
5 Polidocanol 💬[1] Polidocanol (Polyethylene glycol 450 lauryl ether)[1] Polidocanol--[3] 34, 278, 279 💬
6 Polyethylene glycol 3350 💬
(Polyethylene glycol 3350 (USP), Polyethylene glycol (NF))		[1] Polyethylene glycol (Polyethylene glycol)[3] Macrogol; Macrogol 3350; Polyethylene glycol--[4] 50, 97, 195, 299 💬